Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:55 PM
Ignite Modification Date:
2025-12-24 @ 11:55 PM
NCT ID:
NCT07058051
Eligibility Criteria:
Inclusion Criteria:
* Male and female patients, age ≥ 12.
* Chinese patients meet the diagnosis of Non-Segmental Vitiligo (NSV) and 5≤ Total Vitiligo Area Scoring Index (T-VASI\<50) with or without facial involvement.
* Medical history available within the last 6 months.
* Ability to understand the questionnaires, with parental support as required for adolescents (between ≥ 12 and \< 18 years of age at inclusion visit).
* Willing to provide a patient authorization form to use and disclose personal health information (or informed consent, where applicable) to participate in the study; for adolescent subjects, authorization and/or consent will be provided by a parent or legal guardian, where applicable.
Exclusion Criteria:
* Unable or unwilling to comply with study requirements and electronic Patient-Reported Outcome (ePRO) collection.
* Segmental or localized vitiligo.
* Greater than 33% leukotrichia in areas of vitiligo on the face or on the body.
* History of active skin disease other than vitiligo that could interfere with the assessment of vitiligo.
* Patients who are participating in interventional clinical trial(s) at time of study visit.
* Patients who are currently receiving treatment with any investigational drug/device/intervention or have received any investigational product within 1 month or 5 half-lives of the investigational agent (whichever is longer) prior to enrollment.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
12 Years
Maximum Age:
99 Years
Study:
NCT07058051
Study Brief:
Protocol Section:
NCT07058051